Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients

Clinical Neurology and Neurosurgery

Volumn 115, Issue 10, 2013, Pages 2142-2146

  Behm, Timo ^a   Horowski, Antonia ^a   Schneider, Simon ^a   Bock, Hans Christoph ^a   Mielke, Dorothee ^a   Rohde, Veit ^a   Stockhammer, Florian ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Elderly; Glioblastoma; Matched pairs; Radiochemotherapy

Indexed keywords

BEVACIZUMAB; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; GERIATRICS; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; TREATMENT DURATION;

ELDERLY; GLIOBLASTOMA; MATCHED PAIRS; RADIOCHEMOTHERAPY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84884531941     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.08.002     Document Type: Article

References (25)

1. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma New England Journal of Medicine 352 2005 987 996
2. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, and R.C. Janzer Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncology 10 2009 459 466
3. W. Wick, M. Platten, C. Meisner, J. Felsberg, G. Tabatabai, and M. Simon Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Lancet Oncology 13 2012 707 715
4. A. Malmstrom, B.H. Gronberg, C. Marosi, R. Stupp, D. Frappaz, H. Schultz Nordic Clinical Brain Tumour Study G Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncology 13 2012 916 926
5. F.G. Barker 2nd, S.M. Chang, D.A. Larson, P.K. Sneed, W.M. Wara, and C.B. Wilson Age and radiation response in glioblastoma multiforme Neurosurgery 49 2001 1288 1297 discussion 1297-1288
6. K. Abhinav, K. Aquilina, H. Gbejuade, M. La, K. Hopkins, and V. Iyer A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival Clinical Neurology and Neurosurgery 2013 10.1016/j.clineuro.2012.12.023
7. L.L. Kupper Matching P. Armitage, T. Colton, Encyclopedia of biostatistics vol. 3 1998 John Wiley & Sons Chichester, New York, Weinheim, Brisbane, Singapore, Toronto 2441 2445
8. S. Yovino, and S.A. Grossman Treatment of glioblastoma in "elderly" patients Current Treatment Options in Oncology 12 2011 253 262
9. R.O. Mirimanoff, T. Gorlia, W. Mason, M.J. Van den Bent, R.D. Kortmann, and B. Fisher Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial Journal of Clinical Oncology 24 2006 2563 2569
10. W. Stummer, U. Nestler, F. Stockhammer, D. Krex, B.C. Kern, and H.M. Mehdorn Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA Journal of Neuro-Oncology 103 2011 361 370
11. D.R. Johnson, and B.P. O'Neill Glioblastoma survival in the United States before and during the temozolomide era Journal of Neuro-Oncology 107 2012 359 364
12. G. Mariniello, C. Peca, M. del Basso de Caro, A. Giamundo, R. Donzelli, and F. Maiuri Glioblastoma in the elderly: the impact of the advanced age on treatment and survival Journal of Neurological Surgery Part A: Central European Neurosurgery 2013 10.1055/s-0033-1349713
13. W. Stummer, U. Pichlmeier, T. Meinel, O.D. Wiestler, F. Zanella, and H.J. Reulen Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncology 7 2006 392 401
14. C.A. Saether, M. Torsteinsen, S.H. Torp, S. Sundstrom, G. Unsgard, and O. Solheim Did survival improve after the implementation of intraoperative neuronavigation and 3D ultrasound in glioblastoma surgery? A retrospective analysis of 192 primary operations Journal of Neurological Surgery Part A: Central European Neurosurgery 73 2012 73 78
15. U. Pichlmeier, A. Bink, G. Schackert, and W. Stummer Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients Neuro-Oncology 10 2008 1025 1034
16. A.E. Sijben, J.B. McIntyre, G.B. Roldan, J.C. Easaw, E. Yan, and P.A. Forsyth Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme Journal of Neuro-Oncology 89 2008 97 103
17. S.E. Combs, J. Wagner, M. Bischof, T. Welzel, F. Wagner, and J. Debus Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients International Journal of Radiation Oncology, Biology, Physics 70 2008 987 992
18. J.G. Perez-Larraya, F. Ducray, O. Chinot, I. Catry-Thomas, L. Taillandier, and J.S. Guillamo Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial Journal of Clinical Oncology 29 2011 3050 3055
19. P. Hau, D. Koch, T. Hundsberger, E. Marg, B. Bauer, and R. Rudolph Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma Neurology 68 2007 688 690
20. D. Osoba, M. Brada, W.K. Yung, and M. Prados Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme Journal of Clinical Oncology 18 2000 1481 1491
21. W. Roa, P.M. Brasher, G. Bauman, M. Anthes, E. Bruera, and A. Chan Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial Journal of Clinical Oncology 22 2004 1583 1588
22. E.L. Chang, W. Yi, P.K. Allen, V.A. Levin, R.E. Sawaya, and M.H. Maor Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors International Journal of Radiation Oncology, Biology, Physics 56 2003 519 528
23. R. Muni, G. Minniti, G. Lanzetta, P. Caporello, A. Frati, and M.M. Enrici Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma Tumori 96 2010 60 64
24. M. Reyngold, A.B. Lassman, T.A. Chan, Y. Yamada, P.H. Gutin, and K. Beal Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status Journal of Neuro-Oncology 110 2012 369 374
25. J.Q. Cao, B.J. Fisher, G.S. Bauman, J.F. Megyesi, C.J. Watling, and D.R. Macdonald Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience Journal of Neuro-Oncology 107 2012 395 405